The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuartix Tech Regulatory News (QTX)

Share Price Information for Quartix Tech (QTX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 155.00
Bid: 150.00
Ask: 160.00
Change: 0.00 (0.00%)
Spread: 10.00 (6.667%)
Open: 155.00
High: 155.00
Low: 155.00
Prev. Close: 155.00
QTX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Changes

19 Feb 2024 07:00

RNS Number : 5033D
Quartix Technologies PLC
19 February 2024
 

Quartix Technologies plc

("Quartix", "the Group" or "the Company")

Directorate Changes

Quartix Technologies plc, a leading supplier of subscription-based vehicle tracking systems, analytical software and services is pleased to announce the appointment of Ian Spence as independent Non-Executive Director, effective from 19 February 2024. Ian will also Chair the Nomination Committee.

Ian has more than 25 years' experience in researching and advising companies in the technology sector. He is the Executive Chairman and Founder of Megabuyte, a leading company intelligence platform, delivering insights on the financial performance and corporate strategy of UK mid-market tech businesses.

Ian is recognized as one of the most established and respected financial analysts in the technology sector having been twice voted TechMARK Analyst of the Year, and also having been recognized twice by Debretts and The Sunday Times as one of the 20 most influential people in the technology sector in the United Kingdom.

Ian's other current roles include sitting as Non-Executive Director of Crown Place VCT PLC, a fund investing in early stage technology companies and as Principal at Agnosco Capital Ltd, where he provides research and strategic advice to technology companies and their investors.

Andy Walters, Executive Chairman, commented:

"We are delighted to announce Ian's appointment as an independent Non-Executive Director. Ian is one of the most distinguished tech analysts in the UK mid-market and we very much look forward to benefitting from his vast experience and market insight as we continue to execute on our growth strategy"

For further information, please contact:

Quartix (www.quartix.net)

Andy Walters, Executive Chairman

Emily Rees, Chief Financial Officer

01686 806 663

Cavendish Capital Markets Limited (Nominated Adviser and Broker)

Matt Goode / Seamus Fricker / Trisyia Jamaludin (Corporate Finance)

Tim Redfern / Sunila de Silva (Corporate Broking)

020 7220 0500

 

--------------------------------------------------------------------------------------------------------------------------------------

INFORMATION REQUIRED UNDER RULE 17 AND SCHEDULE 2, PARAGRAPH (G) OF THE AIM RULES FOR COMPANIES ("AIM RULES")

Full name:

Ian Angus Spence

Age:

53

Shares held in the Company:

Nil

 

Current directorships and/or partnerships:

Historic directorships and/or partnerships (within the last five years):

 

Agnosco Capital Limited

 

Crown Place VCT plc

 

IS Research Ltd (T/A Megabuyte)

 

 

IX Acquisition Corp Inc

 

 

There is no further information to be disclosed in relation to the appointment pursuant to Rule 17 and Schedule 2, paragraph (g) of the AIM Rules.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAKAKFFPLEFA
Date   Source Headline
27th Mar 20244:00 pmRNSResult of AGM
27th Mar 20247:00 amRNSAGM Trading Statement and Directorate Change
4th Mar 20247:00 amRNSFinal Results
19th Feb 20247:00 amRNSDirectorate Changes
24th Jan 20245:45 pmRNSHolding(s) in Company
23rd Jan 20245:00 pmRNSDirector/PDMR Shareholding - Replacement
23rd Jan 20241:09 pmRNSDirector/PDMR Shareholding
17th Jan 20243:51 pmRNSHolding(s) in Company
17th Jan 20241:45 pmRNSHolding(s) in Company
9th Jan 20247:00 amRNSTrading Statement
18th Dec 202311:45 amRNSHolding(s) in Company
11th Dec 20237:00 amRNSKonetik update
28th Nov 20237:00 amRNSDirectorate Changes
10th Nov 20234:01 pmRNSDirector/PDMR Shareholding
11th Oct 20237:00 amRNSBoard Changes - Replacement
10th Oct 20235:00 pmRNSBoard Changes
6th Oct 20237:00 amRNSTrading Update
26th Sep 20237:00 amRNSDirectorate Change
21st Sep 202311:00 amRNSDirector/PDMR Shareholding
15th Sep 20237:00 amRNSAcquisition of Konetik GmBH
3rd Aug 20233:50 pmRNSDirector/PDMR Shareholding
31st Jul 20237:00 amRNSInterim Results
10th Jul 20237:00 amRNSInterim Results Timetable and Trading Update
7th Jul 20237:00 amRNSDirectorate Change
12th Jun 20231:45 pmRNSPDMR Shareholding
28th Mar 20235:40 pmRNSPDMR Shareholding
24th Mar 20236:05 pmRNSResult of AGM
24th Mar 20237:00 amRNSAGM Trading Statement
22nd Mar 20234:40 pmRNSPDMR Shareholding
27th Feb 20237:00 amRNSFinal Results
11th Jan 20237:00 amRNSTrading Statement
22nd Dec 20223:00 pmRNSSurrender and Granting of Options
20th Dec 20222:30 pmRNSDirectorate Succession
6th Dec 202211:40 amRNSHolding(s) in Company
10th Oct 20227:00 amRNSTrading Update
9th Sep 20225:20 pmRNSHolding(s) in Company
1st Aug 20222:11 pmRNSHolding(s) in Company
27th Jul 20227:00 amRNSInterim Results
11th Jul 20227:00 amRNSInterim Results Timetable and Trading Update
8th Jun 20223:45 pmRNSPDMR Shareholding
7th Jun 20225:10 pmRNSPDMR Shareholding
25th May 20221:10 pmRNSExercise of Share Options
26th Apr 20223:25 pmRNSPDMR Shareholding
25th Apr 20221:10 pmRNSPDMR Shareholding
20th Apr 202210:35 amRNSHolding(s) in Company
14th Apr 202210:40 amRNSPDMR Shareholding
7th Apr 20225:15 pmRNSPDMR Shareholding
4th Apr 20223:55 pmRNSPDMR Shareholding
23rd Mar 20224:45 pmRNSResult of AGM
23rd Mar 20227:00 amRNSAGM Trading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.